Detalhe da pesquisa
1.
Circulating matrix metalloproteinases are associated with arterial stiffness in patients with type 1 diabetes: pooled analysis of three cohort studies.
Cardiovasc Diabetol
; 16(1): 139, 2017 10 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-29070037
2.
Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study.
Cardiovasc Diabetol
; 14: 31, 2015 Mar 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-25848912
3.
Is standardized cardiac assessment of asymptomatic high-risk renal transplant candidates beneficial?
Nephrol Dial Transplant
; 26(9): 3006-12, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21321004
4.
Erratum to: Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study.
Cardiovasc Diabetol
; 14: 128, 2015 Sep 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-26415611